Josh Makower is currently a General Partner on NEA's healthcare team and focuses primarily on medical devices and consumer health technologies. Josh is also the Founder and CEO of ExploraMed I, II, III, and IV Inc., a series of NEA portfolio medical device incubators based on the West Coast that have created eight companies over the past 20 years. In addition, Josh serves a part-time role on the faculty of the Stanford University Medical School as a Consulting Professor of Medicine and is Co-Founder of Stanford’s Biodesign Innovation Program. Josh serves on the board of directors for ExploraMed II, III and IV, Intrinsic Therapeutics, Inc., NeoTract, Inc., Moximed, Inc., Ceterix, Inc., Nuelle, Inc, NC7 Inc. and Coravin. Prior to NEA, Josh was Founder and Manager of Pfizer’s Strategic Innovation Group. Josh holds over one hundred patents for various medical devices in the fields of cardiology, ENT, general surgery, drug delivery, obesity, orthopedics, women’s health, and urology. He received an MBA from Columbia University, a medical degree from the New York University School of Medicine, and a bachelor's degree in Mechanical Engineering from the Massachusetts Institute of Technology.